Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Radiation-related heart toxicity: Update in women].
Marlière S, Vautrin E, Saunier C, Chaikh A, Gabelle-Flandin I. Marlière S, et al. Among authors: gabelle flandin i. Ann Cardiol Angeiol (Paris). 2016 Dec;65(6):411-419. doi: 10.1016/j.ancard.2016.10.012. Epub 2016 Nov 11. Ann Cardiol Angeiol (Paris). 2016. PMID: 27842711 Review. French.
[The impact of radiation therapy on sexual function].
Leroy T, Gabelle Flandin I, Habold D, Hannoun-Lévi JM. Leroy T, et al. Cancer Radiother. 2012 Sep;16(5-6):377-85. doi: 10.1016/j.canrad.2012.05.012. Epub 2012 Aug 23. Cancer Radiother. 2012. PMID: 22921960 Review. French.
Economic evaluation and budget-impact of accelerated partial breast irradiation (APBI) versus standard or hypofractionated whole breast irradiation (WBI) in postmenopausal women with early-stage breast cancer. Results from the French SHARE randomized trial.
Le Bras A, Belkacemi Y, Bourgier C, Gabelle-Flandin I, Petit A, Guilbert P, Geffrelot J, Racadot S, Rivin Del Campo E, Hanzen C, Charra Brunaud C, Auzac G, Lacornerie T, Lemonnier J, Lartigau E, Durand-Zaleski I. Le Bras A, et al. Among authors: gabelle flandin i. Radiother Oncol. 2023 Oct;187:109818. doi: 10.1016/j.radonc.2023.109818. Epub 2023 Jul 20. Radiother Oncol. 2023. PMID: 37480995 Clinical Trial.
Quality of life after breast-conserving therapy and adjuvant radiotherapy for non-low-risk ductal carcinoma in situ (BIG 3-07/TROG 07.01): 2-year results of a randomised, controlled, phase 3 trial.
King MT, Link EK, Whelan TJ, Olivotto IA, Kunkler I, Westenberg AH, Gruber G, Schofield P, Chua BH; BIG 3-07/TROG 07.01 trial investigators. King MT, et al. Lancet Oncol. 2020 May;21(5):685-698. doi: 10.1016/S1470-2045(20)30085-1. Epub 2020 Mar 20. Lancet Oncol. 2020. PMID: 32203696 Clinical Trial.
Pathologic Response to Neoadjuvant Sequential Chemoradiation Therapy in Locally Advanced Breast Cancer: Preliminary, Translational Results from the French Neo-APBI-01 Trial.
To NH, Gabelle-Flandin I, Luong TMH, Loganadane G, Ouidir N, Boukhobza C, Grellier N, Verry C, Thiolat A, Cohen JL, Radosevic-Robin N, Belkacemi Y. To NH, et al. Among authors: gabelle flandin i. Cancers (Basel). 2023 Mar 29;15(7):2030. doi: 10.3390/cancers15072030. Cancers (Basel). 2023. PMID: 37046691 Free PMC article.
Atypical responses to neoadjuvant chemotherapy combined with accelerated partial breast tumor-directed radiotherapy: two cases and considerations for future clinical trials.
To NH, Kossai M, Ouidir N, Grellier N, Assaf E, Gabelle-Flandin I, Belkacemi Y, Radosevic-Robin N. To NH, et al. Among authors: gabelle flandin i. Rep Pract Oncol Radiother. 2022 Dec 29;27(6):1114-1118. doi: 10.5603/RPOR.a2022.0112. eCollection 2022. Rep Pract Oncol Radiother. 2022. PMID: 36632297 Free PMC article. No abstract available.
11 results